Sign in

NCT06230016Active, not recruiting

Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program

Evaluation of the Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

Adapted physical activity session with a formed professional is proposed in standard care since 2022 in the immuno-hematological service to all children with newly diagnosed cancer or relapse. The aim of this study is to keep the children in the APA programm during all the treatment lenght. This study aims to evaluate by questionnaires the motivation keys and restraint from children and parents before the APA program starts (at diagnosis or relapse if not previously participating to an APA programm) and after 4 to 6 months of APA programm. The final expected fallout is to enhance children adhesion to long term APA program by implementing tools in current practice to overcome restraints from young patients and their parents

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
38 (actual)
First submitted
26 Dec 2023
Start date
16 Feb 2024
Primary completion date
27 Feb 2026
Lead sponsor
University Hospital, Grenoble
NCT number
NCT06230016

What you commit to

  • Study type: Observational
  • Participants enrolled: 38
  • From 16 Feb 2024 to the primary completion date, 27 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient with a strict medical contraindication to physical activity identified by the referring physician or another specialist physician, particularly the sports physician (unstabilized heart or lung disease, uncontrolled diabetes, etc.)

Who the study is looking for

  • Patients aged 3 years to under 18 years under care at Grenoble Alpes University Hospital
  • New cancer diagnosis or relapse in the absence of previous APA treatment
  • All cancer pathologies:
    • Diagnosis of acute or chronic hematological malignancy OR Central nervous system tumors OR Other solid tumors
  • Regardless of therapeutic pathway
  • Parents and patient over 5 years old understanding french langage
  • Patient and parents who have not objected to participation after being informed

Age in the registry: 3 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Grenoble Alpes
Coordinator of this site? Confirm its status
GrenobleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.